Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.

Journal of gynecologic oncology - 1 Nov 2023

Kim Yoo-Na, Chung Yun Soo, Lee Ji Hyun, Park Eunhyang, Lee Seung-Tae, Kim Sunghoon, Lee Jung-Yun

Abstract excerpt

OBJECTIVE: To evaluate the landscape of gene alterations and immunohistochemistry (IHC) profiles of patients with ovarian cancer for targeted therapy and investigate the real-world experience of applying precision medicine. METHODS: Patients diagnosed with ovarian cancer between January 2015 and May 2021 at Severance Hospital and who underwent tumor next-generation sequencing (NGS) were reviewed. Data on germline...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B7-H1 Antigen
Share to Class I Phosphatidylinositol 3-Kinases

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to High-Throughput Nucleotide Sequencing

Share to Immunohistochemistry

Share to Mutation

Share to Ovarian cancer diagnosis and treatment

Share to Ovarian Neoplasms

Share to Precision Medicine

Source

Open in PubMed Open full text

Identifiers

PMID: 37417298
DOI: 10.3802/jgo.2023.34.e70
PMCID: PMC10627761

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience.PMID 37417298Read ↗

Next Generation Sequencing and Molecular Biomarkers in Ovarian Cancer—An Opportunity for Targeted TherapySemantic proximity Read ↗

Applying Precision Medicine to Ovarian Cancer: Proof-of-Principle for a "Molecular Second Look".Semantic proximity Read ↗

[Analysis of homologous recombination deficiency testing in ovarian cancer based on next-generation sequencing].Semantic proximity Read ↗

Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.Semantic proximity Read ↗

Next-Generation Sequencing in Breast Cancer Patients: Real-World Data for Precision Medicine.Semantic proximity Read ↗

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in OncologySemantic proximity Read ↗

The Role of Next-Generation Sequencing in Precision Medicine: A Review of Outcomes in OncologySemantic proximity Read ↗

Molecular Guided Treatments in Gynecologic Oncology: Analysis of a Real-World Precision Cancer Medicine Platform.Semantic proximity Read ↗

Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?Semantic proximity Read ↗

Development of New Cancer Treatment by Identifying and Focusing the Genetic Mutations or Altered Expression in Gynecologic Cancers.Semantic proximity Read ↗

Precision medicine at Memorial Sloan Kettering Cancer Center: clinical next-generation sequencing enabling next-generation targeted therapy trialsSemantic proximity Read ↗

Clinical availability and characteristics of multigene panel testing for recurrent/advanced gynecologic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.